- Stocks
- Pharma & Healthcare
- IOL Chemicals and Pharmaceuticals
IOL Chemicals and Pharmaceuticals share price
NSE: IOLCPPharma & HealthcareDrug Manufacturers - Specialty & Generic
IOL Chemicals and Pharmaceuticals at a glance
IOL Chemicals and Pharmaceuticals (NSE: IOLCP) closed at ₹173.27 on 22 Oct 2026, down 0.76% on the day. With a market capitalisation of ₹5,086 Cr, it ranks 778th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.
At its last close the stock traded at 36.9× trailing earnings, against a return on equity of 6.0% in FY25. Over the past year the share price has risen 80.5%. Its 52-week range is ₹67.19 (16 Mar 2026) to ₹224.00 (7 Oct 2026); the last close is 22.6% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹619 Cr (+17.4% year on year) and net profit ₹53 Cr (+69.2%), on a consolidated basis. Promoters held 62.28% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹5,086 CrRank 778 on NSE
- P/E (trailing)
- 36.9×
- Price to book
- 1.06×FY25
- EPS (TTM)
- ₹4.69to Q4 FY26
- ROE
- 6.0%FY25
- ROCE
- 8.6%FY25
- Debt to equity
- 0.07FY25
- Net profit margin
- 4.9%FY25
- Book value / share
- ₹57.49FY25
- Dividend payout
- 23.2%FY25
- 52-week high
- ₹224.007 Oct 2026
- 52-week low
- ₹67.1916 Mar 2026
- 1-year return
- +80.5%
- RSI (14-day)
- 35.8
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | −0.76% | −15.1% | −14.4% | +17.1% | +80.5% |
IOL Chemicals and Pharmaceuticals quarterly results
| Quarter | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹502 Cr | ₹526 Cr | ₹523 Cr | ₹528 Cr | ₹552 Cr | ₹568 Cr | ₹580 Cr | ₹619 Cr |
| Revenue YoY | −10.8% | −3.6% | +0.6% | +4.7% | +9.8% | +7.9% | +10.9% | +17.4% |
| Net profit | ₹30 Cr | ₹19 Cr | ₹21 Cr | ₹31 Cr | ₹34 Cr | ₹30 Cr | ₹21 Cr | ₹53 Cr |
| Net profit YoY | −34.6% | −49.4% | −11.0% | +13.8% | +13.2% | +56.5% | +0.2% | +69.2% |
| Net margin | 6.0% | 3.6% | 3.9% | 6.0% | 6.2% | 5.3% | 3.5% | 8.6% |
| EPS | ₹5.11 | ₹3.26 | ₹3.50 | ₹1.07 | ₹1.16 | ₹1.02 | ₹0.70 | ₹1.81 |
IOL Chemicals and Pharmaceuticals financials
| Item | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Revenue | ₹2,184 Cr | ₹2,217 Cr | ₹2,133 Cr | ₹2,079 Cr |
| Operating profit | ₹239 Cr | ₹189 Cr | ₹182 Cr | ₹138 Cr |
| Net profit | ₹168 Cr | ₹139 Cr | ₹134 Cr | ₹101 Cr |
| EPS (₹) | ₹29.00 | ₹24.00 | ₹23.00 | ₹3.00 |
| Cash from operations | ₹93 Cr | ₹122 Cr | ₹290 Cr | ₹179 Cr |
| Total debt | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Shareholders' equity | ₹1,392 Cr | ₹1,508 Cr | ₹1,612 Cr | ₹1,688 Cr |
IOL Chemicals and Pharmaceuticals shareholding pattern
| Holder | 31 Mar 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 52.62% | 52.62% | 52.62% | 52.62% | 57.48% | 62.28% |
| Foreign institutions | 1.47% | 2.59% | 2.25% | 2.08% | 1.72% | 4.87% |
| Domestic institutions | 0.07% | 0.02% | 0.04% | 0.03% | 0.02% | 0.43% |
| Non-institutions | 45.83% | 44.76% | 45.09% | 45.27% | 40.78% | 32.42% |
IOL Chemicals and Pharmaceuticals vs peers
The listed Pharma & Healthcare companies nearest to IOL Chemicals and Pharmaceuticals by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| SPARCSun Pharma Advanced Research Company | ₹176.82 | −1.22% | +35.4% | ₹5,738 Cr | 3.7 | — |
| SENORESSenores Pharmaceuticals | ₹1,233.30 | +0.35% | +71.0% | ₹5,680 Cr | 46.7 | — |
| INNOVACAPInnova Captab | ₹983.60 | +0.57% | +17.9% | ₹5,629 Cr | 40 | — |
| FDCFDC | ₹339.20 | −0.24% | −22.1% | ₹5,523 Cr | — | — |
| IOLCPIOL Chemicals and Pharmaceuticals | ₹173.27 | −0.76% | +80.5% | ₹5,086 Cr | 36.9 | — |
| RPGLIFERPG Life Sciences | ₹2,754.80 | −2.31% | +18.9% | ₹4,556 Cr | 39.6 | — |
| ZOTAZota Health Care | ₹1,304.00 | −0.76% | −12.1% | ₹4,516 Cr | — | — |
Ask anything about IOL Chemicals and Pharmaceuticals
Pivot answers on the live chart with evidence you can check, and tests strategies against IOLCP's own history. Try: “Why has IOLCP moved over the last three months?” · “Backtest a 50-day moving-average crossover on IOLCP over five years” · “Compare IOLCP with SPARC on margins and valuation”
Frequently asked questions about IOL Chemicals and Pharmaceuticals
What is the share price of IOL Chemicals and Pharmaceuticals today?
IOL Chemicals and Pharmaceuticals (NSE: IOLCP) last closed at ₹173.27 on 22 Oct 2026. Its 52-week high is ₹224.00 and its 52-week low is ₹67.19.
What is the market cap of IOL Chemicals and Pharmaceuticals?
IOL Chemicals and Pharmaceuticals' market capitalisation is ₹5,086 Cr (₹5,086 Cr) at the 22 Oct 2026 close, ranking 778th among the NSE companies Pivot tracks.
What is the P/E ratio of IOL Chemicals and Pharmaceuticals?
IOL Chemicals and Pharmaceuticals trades at a trailing P/E of 36.9. The median P/E of the 4 closest Pharma & Healthcare peers by market cap is 40.
What is the ROE and ROCE of IOL Chemicals and Pharmaceuticals?
Return on equity was 6.0% in FY25 and return on capital employed was 8.6% in FY25 (consolidated figures).
Is IOL Chemicals and Pharmaceuticals a debt-free company?
No. IOL Chemicals and Pharmaceuticals' debt-to-equity ratio was 0.07 in FY25, with total debt of ₹0 Cr.
What were IOL Chemicals and Pharmaceuticals' latest quarterly results?
For Q4 FY26 (quarter ended 31 Mar 2026), IOL Chemicals and Pharmaceuticals reported revenue of ₹619 Cr, +17.4% year on year, and net profit of ₹53 Cr, +69.2% year on year.
How has IOL Chemicals and Pharmaceuticals stock performed over the last year?
IOL Chemicals and Pharmaceuticals' share price has risen 80.5% over the past year, +17.1% over three months and −14.4% over one month, to the 22 Oct 2026 close.
What is the shareholding pattern of IOL Chemicals and Pharmaceuticals?
As of 30 Jun 2026: promoters 62.28%, foreign institutions 4.87%, domestic institutions 0.43%, non-institutions 32.42%.
Who are IOL Chemicals and Pharmaceuticals' competitors?
The listed Pharma & Healthcare companies closest to IOL Chemicals and Pharmaceuticals by market cap are Sun Pharma Advanced Research Company, Senores Pharmaceuticals, Innova Captab, FDC, RPG Life Sciences and Zota Health Care.
Is IOL Chemicals and Pharmaceuticals a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out IOL Chemicals and Pharmaceuticals' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on IOLCP against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with I · all NSE stocks · this page as text